{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:51:50Z","timestamp":1791546710490,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shandong Provincial Natural Science Foundation","award":["ZR2024QH424"],"award-info":[{"award-number":["ZR2024QH424"]}]},{"name":"Scientific Research Innovation Program Project of Shandong Second Medical University","award":["2024BKQ007"],"award-info":[{"award-number":["2024BKQ007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61515-5","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:47:13Z","timestamp":1783604833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and psychometric evaluation of a symptom assessment scale for adjuvant radiotherapy in breast cancer patients based on the symptom experience model"],"prefix":"10.1038","volume":"16","author":[{"given":"Shuo","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-6502","authenticated-orcid":false,"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"61515_CR1","doi-asserted-by":"crossref","unstructured":"Hao, J. et al. Global burden of breast cancer and application of patient-reported outcomes in clinical trials: A systematic analysis based on the global burden of disease study 2021 and WHO international clinical trial register database [J]. Front. Oncol. 15 (2025).","DOI":"10.3389\/fonc.2025.1557080"},{"key":"61515_CR2","doi-asserted-by":"crossref","unstructured":"Deng, T. et al. Global, regional, and national burden of breast cancer, 1990\u20132021, and projections to 2050: A systematic analysis of the global burden of disease study 2021 [J]. Thorac. Cancer 16(9). (2025).","DOI":"10.1111\/1759-7714.70052"},{"key":"61515_CR3","first-page":"721","volume":"15","author":"J Wang","year":"2023","unstructured":"Wang, J. & Wu, S. Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives [J]. Breast cancer. 15, 721\u2013723 (2023).","journal-title":"Breast cancer"},{"issue":"1","key":"61515_CR4","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1038\/s41598-023-29888-z","volume":"13","author":"M Miyashita","year":"2023","unstructured":"Miyashita, M. et al. The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions[J]. Sci. Rep. 13 (1), 2880 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"61515_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12905-024-03165-1","volume":"24","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. Survival benefits of postoperative radiotherapy in patients with cT1\u20132N1M0 breast cancer after neoadjuvant chemotherapy: a SEER-based population study[J]. BMC Women\u2019s Health. 24 (1), 324 (2024).","journal-title":"BMC Women\u2019s Health"},{"key":"61515_CR6","doi-asserted-by":"crossref","unstructured":"Kuszaj, O. et al. Validation of the skin symptom assessment (SSA) questionnaire for the evaluation of radiation dermatitis in breast cancer patients[J]. Support. Care Cancer Off. J. Multinational Assoc. Supportive Care Cancer 32(10) (2024).","DOI":"10.1007\/s00520-024-08890-9"},{"issue":"1","key":"61515_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1186\/s12885-025-14381-9","volume":"25","author":"K Breek","year":"2025","unstructured":"Breek, K. et al. Self-reported side effects of breast cancer treatment and its impact on quality of life: a multicenter cross-sectional study in a low- and middle-income country[J]. BMC Cancer. 25 (1), 975 (2025).","journal-title":"BMC Cancer"},{"issue":"1","key":"61515_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/jin.jin_122_23","volume":"6","author":"GH Uslu","year":"2024","unstructured":"Uslu, G. H., Aydin, A. & G\u00dcrsoy, A. Changes in acute and late toxicity and patient-reported health-related quality of life following radiotherapy in women with breast cancer: a 1-year longitudinal study [J]. J. Integr. Nurs. 6 (1), 15\u201321 (2024).","journal-title":"J. Integr. Nurs."},{"key":"61515_CR9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3332\/ecancer.2023.1533","volume":"17","author":"R Rai","year":"2023","unstructured":"Rai, R. et al. Assessment of late treatment-related symptoms using patient-reported outcomes and various factors affecting return to work in survivors of breast cancer [J]. Ecancermedicalscience 17, 1533 (2023).","journal-title":"Ecancermedicalscience"},{"key":"61515_CR10","doi-asserted-by":"crossref","unstructured":"Cai, T. et al. Psychometric properties of the chinese version of the functional assessment of chronic illness therapy-fatigue (FACIT-F) among patients with breast cancer [J] Vol. 21, 91 (Health and Quality of Life Outcomes, 2023). 1.","DOI":"10.1186\/s12955-023-02164-4"},{"issue":"1","key":"61515_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13058-025-02036-3","volume":"27","author":"P Heumann","year":"2025","unstructured":"Heumann, P. et al. Prognostic value of cancer-related fatigue at the end of radiotherapy for overall survival\u2009\u2265\u200910 years in women with breast cancer [J]. Breast Cancer Research: BCR. 27 (1), 76 (2025).","journal-title":"Breast Cancer Research: BCR"},{"issue":"6","key":"61515_CR12","first-page":"394","volume":"32","author":"X Lu","year":"2024","unstructured":"Lu, X. et al. Acute skin toxicity and self-management ability among chinese breast cancer radiotherapy patients: a qualitative study [J]. Support. Care Cancer. 32 (6), 394 (2024).","journal-title":"Support. Care Cancer"},{"issue":"1","key":"61515_CR13","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.1038\/s41598-025-91569-w","volume":"15","author":"C Touraine","year":"2025","unstructured":"Touraine, C. et al. Impact of adapted physical activity and diet counselling on health-related quality of life in women undergoing adjuvant breast cancer therapy[J]. Sci. Rep. 15 (1), 8215 (2025).","journal-title":"Sci. Rep."},{"issue":"6","key":"61515_CR14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1177\/10781552241266574","volume":"31","author":"A Isah","year":"2025","unstructured":"Isah, A. et al. A two-tool assessment of the quality of life of patients with breast cancer using generic and disease-specific tools in a nigerian teaching hospital[J]. J. Oncol. Pharm. Practice: Official Publication Int. Soc. Oncol. Pharm. Practitioners. 31 (6), 929\u2013938 (2025).","journal-title":"J. Oncol. Pharm. Practice: Official Publication Int. Soc. Oncol. Pharm. Practitioners"},{"issue":"11","key":"61515_CR15","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/curroncol32110598","volume":"32","author":"S Torres","year":"2025","unstructured":"Torres, S. et al. Using the edmonton symptom assessment system (ESAS) to describe symptom burden associated with breast cancer and related treatments: a cross-sectional study[J]. Curr. Oncol. (toronto Ont). 32 (11), 598 (2025).","journal-title":"Curr. Oncol. (toronto Ont)"},{"key":"61515_CR16","doi-asserted-by":"crossref","unstructured":"Di Maio, M. et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline[J]. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 33(9). (2022).","DOI":"10.1016\/j.annonc.2022.04.007"},{"key":"61515_CR17","doi-asserted-by":"crossref","unstructured":"Patel, P. et al. Systematic review of the tools and outcomes for the assessment of acute radiation dermatitis severity[J]. Clin. Transl. Radiation Oncol. 53 (2025).","DOI":"10.1016\/j.ctro.2025.100977"},{"key":"61515_CR18","doi-asserted-by":"crossref","unstructured":"Gupta, N. et al. Patient reported outcomes for symptom toxicity in breast cancer patients undergoing radiotherapy[J]. Curr. Probl. Cancer 58. (2025).","DOI":"10.1016\/j.currproblcancer.2025.101236"},{"key":"61515_CR19","doi-asserted-by":"crossref","unstructured":"Hassan, M. et al. Cognitive functioning in women with breast cancer: psychometric properties of the arabic version of the functional assessment of cancer therapy-cognitive function tool[J] Vol. 21 (Health and quality of life outcomes, 2023). 1.","DOI":"10.1186\/s12955-023-02095-0"},{"issue":"4","key":"61515_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1188\/03.ONF.601-606","volume":"30","author":"TS Armstrong","year":"2003","unstructured":"Armstrong, T. S. Symptoms experience: a concept analysis[J]. Oncol. Nurs. Forum. 30 (4), 601\u2013606 (2003).","journal-title":"Oncol. Nurs. Forum"},{"issue":"4","key":"61515_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.31557\/APJCP.2023.24.4.1435","volume":"24","author":"H Safar","year":"2023","unstructured":"Safar, H. & Mazanec, S. R. Relationship between symptom burden and HRQOL among kuwaiti women recently diagnosed with breast cancer: a cross-sectional study[J]. Asian Pac. J. Cancer Prevention: APJCP. 24 (4), 1435\u20131441 (2023).","journal-title":"Asian Pac. J. Cancer Prevention: APJCP"},{"issue":"4","key":"61515_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/2229-3485.86879","volume":"2","author":"PR Deshpande","year":"2011","unstructured":"Deshpande, P. R. et al. Patient-reported outcomes: a new era in clinical research[J]. Perspect. Clin. Res. 2 (4), 137\u2013144 (2011).","journal-title":"Perspect. Clin. Res."},{"key":"61515_CR23","doi-asserted-by":"crossref","unstructured":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance[J] Vol. 4, 79 (Health and Quality of Life Outcomes, 2006).","DOI":"10.1186\/1477-7525-4-79"},{"key":"61515_CR24","doi-asserted-by":"crossref","unstructured":"Puccini, A. et al. Patient-reported outcomes (PROs) in clinical trials and in clinical practice: Report from the XXI national conference of the Italian association of medical oncology (AIOM)[J]. BMJ Oncol. 4(1), e000783 (2025).","DOI":"10.1136\/bmjonc-2025-000783"},{"issue":"3","key":"61515_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/0013164418818242","volume":"79","author":"C DiStefano","year":"2019","unstructured":"DiStefano, C. et al. Fitting large factor analysis models with ordinal data[J]. Educ. Psychol. Meas. 79 (3), 417\u2013436 (2019).","journal-title":"Educ. Psychol. Meas."},{"key":"61515_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12955-014-0180-6","volume":"12","author":"YB Cheung","year":"2014","unstructured":"Cheung, Y. B. et al. Mapping the functional assessment of cancer therapy-breast (FACT-B) to the 5-level EuroQoL group\u2019s 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic asian population[J]. Health Qual. Life Outcomes. 12, 180 (2014).","journal-title":"Health Qual. Life Outcomes"},{"issue":"1","key":"61515_CR27","doi-asserted-by":"publisher","first-page":"e10004","DOI":"10.2196\/10004","volume":"21","author":"LM Matthies","year":"2019","unstructured":"Matthies, L. M. et al. An electronic patient-reported outcome tool for the FACT-B (functional assessment of cancer therapy-breast) questionnaire for measuring the health-related quality of life in patients with breast cancer: reliability study[J]. J. Med. Internet. Res. 21 (1), e10004 (2019).","journal-title":"J. Med. Internet. Res."},{"issue":"11","key":"61515_CR28","doi-asserted-by":"publisher","first-page":"e0336793","DOI":"10.1371\/journal.pone.0336793","volume":"20","author":"W Li","year":"2025","unstructured":"Li, W. et al. Symptom network analysis in breast cancer patients: a scoping review[J]. PloS One. 20 (11), e0336793 (2025).","journal-title":"PloS One"},{"key":"61515_CR29","doi-asserted-by":"crossref","unstructured":"Nieder, C. et al. Patient-reported symptoms before adjuvant locoregional radiotherapy for breast cancer: triple-negative histology impacts the symptom burden[J]. Strahlenther. Onkol., 200(6). (2024).","DOI":"10.1007\/s00066-024-02224-8"},{"key":"61515_CR30","doi-asserted-by":"crossref","unstructured":"Shen, A. et al. Arm symptom pattern among breast cancer survivors with and without lymphedema: A contemporaneous network analysis[J]. Oncologist 29(12) (2024).","DOI":"10.1093\/oncolo\/oyae217"},{"key":"61515_CR31","doi-asserted-by":"crossref","unstructured":"Li, Z. et al. The mediating effect of somatic symptom disorder between psychological factors and quality of life among chinese breast cancer patients[J]. Front. Psychiatry, 14. (2023).","DOI":"10.3389\/fpsyt.2023.1076036"},{"issue":"12","key":"61515_CR32","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","volume":"30","author":"M Lange","year":"2019","unstructured":"Lange, M. et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors[J]. Annals Oncology: Official J. Eur. Soc. Med. Oncol. 30 (12), 1925\u20131940 (2019).","journal-title":"Annals Oncology: Official J. Eur. Soc. Med. Oncol."},{"key":"61515_CR33","doi-asserted-by":"crossref","unstructured":"Amani, O. et al. Chemotherapy-induced cognitive impairment in breast cancer survivors: a systematic review of studies from 2000 to 2021[J]. Cancer Rep. 7(2) (2024). .","DOI":"10.1002\/cnr2.1989"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61515-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61515-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61515-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:02:48Z","timestamp":1791543768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61515-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61515"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61515-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"This study was approved by the Ethics Committee of Weifang People\u2019s Hospital (Approval No.2024YX227). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Ethical guidelines statement","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Informed consent was obtained from all individual participants included in the study participants signed informed consent regarding publishing their data.","order":3,"name":"Ethics","label":"<b>Consent<\/b>","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"31571"}}